David Koeckerling,Rohin K. Reddy,Joseph Barker,Christian Eichhorn,Pip Divall,James P. Howard,Felix Korell,Michael Schmitt,Peter Dreger,Norbert Frey,Lorenz Lehmann
出处
期刊:JAMA network open [American Medical Association] 日期:2024-10-07卷期号:7 (10): e2437222-e2437222被引量:1
The frequency and clinical phenotypes of cardiotoxic events in chimeric antigen receptor (CAR) T-cell recipients remain poorly understood given that landmark approval trials typically exclude patients with high-risk cardiovascular profiles and data from nontrial settings are scarce.